Executive Search Success Story: Building Commercial Leadership for a PE-Backed Diagnostics Company

How JRG Partners executed a highly confidential, multi-role North American retained search strategy that equipped a private equity-backed in-vitro diagnostics (IVD) organization specializing in infectious disease testing with the critical commercial, sales, supply chain, regulatory, and quality systems leadership required to scale high-growth operations, expand market reach, and accelerate value-creation plans[cite: 14].

The Challenge

A private equity-backed IVD organization specializing in infectious disease testing was preparing for aggressive corporate expansion following a series of successful product launches[cite: 14]. To capitalize on market momentum, expand its clinical footprint, and successfully navigate high-growth operational scaling, the platform required a complete evolution of its management bench[cite: 14]. Executive leadership and its sponsor identified several critical pressures[cite: 14]:

• A limited existing leadership infrastructure unable to sustain rapid, large-scale growth[cite: 14]
• Significant structural and strategic difficulty scaling cross-border commercial operations[cite: 14]
• Intense market competition from established, heavily capitalized global diagnostics giants[cite: 14]
• Persistent manufacturing and supply chain bottlenecks affecting commercial availability[cite: 14]
• Acute talent shortages within highly technical regulatory and quality systems functions[cite: 14]
• Pronounced executive succession and leadership continuity concerns within key operational roles[cite: 14]

The platform’s board of directors and private equity sponsor determined that executing its commercial scaling objectives required a synchronized management core spanning a Chief Commercial Officer, VP Sales, VP Supply Chain, VP Regulatory Affairs, VP Quality Systems, Director of Strategic Accounts, and Director of Clinical Affairs[cite: 14]. Successfully delivering this multi-role mandate required an executive search partner combining exact vertical literacy in high-growth healthcare scaling with direct access to a premium network of passive diagnostics talent[cite: 14]. For organizations assessing broader industry frameworks for scaling complex laboratory instrumentation and regulatory workflows, a parallel analysis can be reviewed in In-Vitro_Diagnostics_A_Whitelabeled.docx.

Why They Chose JRG Partners

Deep Diagnostics Commercial Specialization

Unlike generalist recruitment firms that lack practical immersion in life-sciences commercialization pipelines, JRG Partners maintains dedicated executive search practices built explicitly around diagnostics sales, supply chain architecture, regulatory quality systems, and high-growth healthcare platform mechanics[cite: 14]. Our consultants hold an intimate functional understanding of the unique adoption and reimbursement cycles governing the modern IVD sector.

Real Access to Passive Talent

The most effective commercial leaders, supply chain executives, and regulatory experts within the infectious disease testing vertical are typically fully embedded in highly active deployment lifecycles, meaning they rarely look at traditional job listings. JRG Partners bypassed conventional recruitment channels entirely, leveraging long-standing sector relationships, executive circles, and proprietary market intelligence to directly engage high-performing passive leaders invisible to standard sourcing channels[cite: 14].

Confidential Search Execution

Because this leadership build-out took place concurrently with active value-creation plans, sensitive market expansions, and confidential operational transformations, absolute discretion was a baseline requirement[cite: 14]. JRG Partners ran a highly secure, confidential vetting framework that successfully protected the client’s competitive market advantages, preserved ongoing sales operations, and maintained total investor confidence[cite: 14].

True North American Industry Reach

Sourcing specialized clinical, operational, and financial leaders capable of guiding a high-growth platform required an outreach strategy unconstrained by local geography. JRG Partners deployed a coordinated strategy across primary diagnostics and life-sciences markets across North America, delivering a premium shortlist of proven, cross-border executives to the client’s board and private equity sponsors[cite: 14].

Our Executive Search Strategy

Phase 1 — Strategic Alignment & Competency Assessment

Our consultants partnered directly with the CEO, Board, and executive team to systematically map existing organizational gaps, identify hidden succession risks, clarify scaling milestones, and define the exact leadership competencies required for long-term clinical and commercial expansion[cite: 14]. Rather than matching against legacy job descriptions, we built forward-looking executive profiles dynamically tied to the platform’s multi-year growth strategy[cite: 14].

Phase 2 — Specialized Market Mapping

JRG Partners executed an exhaustive market-mapping initiative that targeted high-performing, process-driven environments across North America[cite: 14]. Our comprehensive market map targeted key talent pools across infectious disease diagnostics companies, molecular diagnostics manufacturers, biotechnology organizations, clinical laboratory providers, point-of-care testing companies, precision medicine organizations, and parallel private equity-backed diagnostics businesses[cite: 14].

Phase 3 — Targeted Executive Engagement

Using a research-driven, discreet outreach framework, our consultants directly contacted and evaluated high-achieving executives with verified records of success in diagnostics commercial scaling, strategic accounts management, and regulatory compliance[cite: 14]. Only candidates demonstrating clear, measurable operational, quality, and market-penetration impact advanced to the final evaluation round[cite: 14].

Phase 4 — Rigorous Assessment & Final Selection

Each finalist candidate underwent an extensive evaluation process looking far beyond basic professional credentials[cite: 14]. Our consultants conversion-tested strategic and functional capabilities, healthcare compliance framework agility, team-building and leadership philosophies, cross-functional communication skills, cultural alignment with rapid private equity scaling timelines, and long-term retention potential[cite: 14].

Key Outcomes

• 450+ targeted infectious disease testing, molecular diagnostics, and clinical sales executive profiles systematically mapped across key North American life-sciences and technology corridors[cite: 14].
• Successfully placed and integrated a complete corporate leadership framework—spanning the Chief Commercial Officer, supply chain vice presidents, and clinical affairs directors—within a 10-month timeline[cite: 14].
• Unified separate cross-functional engineering, sales, and quality groups under a single, cohesive deployment strategy by installing process-driven transformation executives.
• Accelerated new-market entry and stabilized strategic healthcare accounts by placing forward-thinking sales and commercial directors[cite: 14].
• Mitigated multi-site logistics risks and relieved immediate component constraints by placing specialized, data-driven supply chain leaders[cite: 14].
• Protected crucial intellectual property, sensitive corporate valuations, and upcoming launch pipelines during a high-stakes transition phase through strict search confidentiality[cite: 14].
• Provided the Board of Directors and PE sponsors with a high-performance management framework explicitly equipped to eliminate long-term succession risks and drive profitable, compliant diagnostics innovation at scale[cite: 14].